Fabtech Technologies profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026
Returns
9.1%9.1%
5.9%5.9%
6.7%6.7%
4.7%6.4%
Margins
6.5%8.5%
7.2%7.2%
12.9%11.7%
9.2%9.3%
−1.0%−1.0%
Additional
29.0%20.7%
9.1%9.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FABTECH₹122.21

Fabtech Technologies Limited

· Pharma & Health
₹ CrorePeersLAXMIDENTLTARSONSFISCHERGKBMcap ₹543 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/09/2026
Returns
Return on Common Equity9.149.14
Return on Assets5.875.87
Return on Capital Employed6.656.65
Return on Invested Capital6.444.74
Margins
EBITDA Margin8.526.47
Operating Margin7.237.23
Pretax Margin11.6512.90
Net Income Margin9.349.17
FCF Margin-1.03-1.03
Additional
Effective Tax Rate20.7129.04
Sustainable Growth Rate9.149.14
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.